Nasdaq:US$15.26 (-0.04) | HKEX:HK$24.10 (+0.15) | AIM:£2.26 (+0.02)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma